Английская Википедия:Faldaprevir
Шаблон:Short description Шаблон:Drugbox
Faldaprevir was an experimental drug for the treatment of hepatitis C (HCV). It was being developed by Boehringer-Ingelheim and reached Phase III clinical trials in 2011.[1] Boehringer announced in 2014 that it would not pursue approval of the drug any more because of better HCV treatments having become available.[2]
Mechanism of action
Faldaprevir is a hepatitis C virus protease inhibitor.Шаблон:Cn
Studies
Faldaprevir was tested in combination regimens with pegylated interferon and ribavirin, and in interferon-free regimens with other direct-acting antiviral agents including deleobuvir.Шаблон:Cn
Data from the SOUND-C2 study, presented at the 2012 AASLD Liver Meeting, showed that a triple combination of faldaprevir, deleobuvir, and ribavirin performed well in HCV genotype 1b patients.[3]
References
- Английская Википедия
- Abandoned drugs
- Cyclopropanes
- NS3/4A protease inhibitors
- Quinolines
- Tert-butyl compounds
- Vinyl compounds
- Thiazoles
- Carboxamides
- Bromoarenes
- Cyclopentyl compounds
- Pyrrolidines
- Carbamates
- Страницы, где используется шаблон "Навигационная таблица/Телепорт"
- Страницы с телепортом
- Википедия
- Статья из Википедии
- Статья из Английской Википедии